Retracted: Up‐regulation of microRNA‐145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells
Authors:
Abstract
BACKGROUND: MicroRNA‐145 (miR‐145) has been reported to be a tumor‐suppressing agent in several studies. It can repress pluripotency and control human embryonic stem cell differentiation by regulating the core pluripotency factor OCT4. However, it is not known whether miR‐145 can play a role in inducing tumor cell differentiation and repressing growth of tumors. METHODS: Ishikawa cells, the established human endometrial cancer cells, were treated with miR‐145 mimics, inhibitor, or small interfering RNA OCT4. miR‐145 levels were assayed using TaqMan microRNA assays, and the messenger RNA levels of OCT4 and the differentiation marker glycodelin were measured using real‐time polymerase chain reaction. The protein levels of OCT4 and glycodelin were characterized via flow cytometry, western blotting, and immunohistochemistry. In vivo activity was measured in a xenograft mouse model. RESULTS: Up‐regulating miR‐145 reduced the expression of OCT4 and induced the differentiation of Ishikawa cells to closely resemble normal endometrial epithelium both in vitro and in vivo. miR‐145 successfully inhibited tumor growth. We also found that in patients with endometrial carcinoma, miR‐145 and OCT4 were expressed in tissues, and there was a relationship between miR‐145, OCT4, and the degree of tumor cell differentiation. CONCLUSIONS: Our results strongly suggested that miR‐145 is a tumor cell differentiation‐inducing agent in endometrial carcinoma, and that miR‐145 or OCT4 may be useful markers for grading endometrial carcinoma. Cancer 2011. © 2011 American Cancer Society.Keywords
This publication has 30 references indexed in Scilit:
- Building a Framework for Embryonic Microenvironments and Cancer Stem CellsStem Cell Reviews and Reports, 2009
- Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation: a clinicopathologic study of 5 cases and review of the literatureHuman Pathology, 2008
- Reprogramming of human somatic cells to pluripotency with defined factorsNature, 2007
- In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like stateNature, 2007
- Analysis of Oct4-Dependent Transcriptional Networks Regulating Self-Renewal and Pluripotency in Human Embryonic Stem CellsStem Cells, 2006
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesisCarcinogenesis, 2004
- Oct-3/4 is a dose-dependent oncogenic fate determinantCancer Cell, 2003
- Stem cells, cancer, and cancer stem cellsNature, 2001
- Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cellsNature Genetics, 2000